An Open Label Study of the Effect of Rituxan, High Dose Methotrexate and High Dose Cytarabine on Response Rate in Patients With Primary Central Nervous System Lymphoma.
Phase of Trial: Phase II
Latest Information Update: 19 Aug 2014
At a glance
- Drugs Rituximab (Primary) ; Cytarabine; Methotrexate
- Indications CNS cancer; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- Sponsors Roche
- 15 Jul 2014 Status changed from completed to discontinued as reported by ClinicalTrials.gov record.
- 12 Mar 2010 Actual patient number (5) added as reported by ClinicalTrials.gov.
- 17 Jul 2009 Actual end date changed from Mar 2009 to May 2009 added as reported by ClinicalTrials.gov.